TP53 and esophageal squamous cell carcinoma: These WES studies reported frequent mutations of TP53, CDKN2A, NOTCH1, RB1, ERBB2 and NFE2L2 in ESCC (Sawada et al., 2016; Song et al., 2014; Qin et al., 2016).